æ°å£çµè¡£ããåºæ¼ã¢ãã²ã¼TVCMãã®WEBéå®ã¹ãã·ã£ã«åç»ã§ãï¼ ã¯ãªã¹ãã¹ã«ã´ã£ããã®åç»ããã²ã楽ãã¿ãã ããï¼
1ï¼ä»¥ä¸ãåç¡ãã«ãããã¾ãã¦VIPããéããã¾ãï¼2011/08/03(æ°´) 03:19:37.64ID:Sp7pXJ440 å¯ãããã 2ï¼ä»¥ä¸ãåç¡ãã«ãããã¾ãã¦VIPããéããã¾ãï¼2011/08/03(æ°´) 03:20:07.15ID:gkfx/Ye80
File Not Found. 該å½ãã¼ã¸ãè¦ã¤ããã¾ãããURLãã確èªä¸ããã ãç¥ãã äºä»¶ã»äºæ ã®ã¸ã£ã³ã«ãé¤ããéå»ï¼å¹´åã®ä¸»ãªè¨äºã¯ãã¤ã³ã¿ã¼ãããã®ä¼å¡å¶ãã¼ã¿ãã¼ã¹ã»ãµã¼ãã¹ã®ã京é½æ°èãã¼ã¿ãã¼ã¹ plus æ¥çµãã¬ã³ã³ãï¼http://telecom.nikkei.co.jp/public/guide/kyoto/ï¼ãããã¯ãæ¥çµãã¬ã³ã³ãï¼æ¬ç¤¾ã»æ±äº¬ãhttp://telecom.nikkei.co.jp/ï¼ããã¸ã¼ã»ãµã¼ãã(æ¬ç¤¾ã»æ±äº¬ã http://www.gsh.co.jp)ã®ãããã§ãè¦ããã¨ãã§ãã¾ããã¾ããç»é²ããã¸ã£ã³ã«ã®è¨äºãæ¯æ¥ããããçµç±ã§ä¼å¡ã«å±ããä¼å¡å¶ãã¼ã¿ãã¼ã¹ã»ãµã¼ãã¹ãã¹ã«ã©ã³ãã¥ãã±ã¼ã·ã§ã³ãºã(æ¬ç¤¾ã»æ±äº¬ãhttp://scala-com.jp/brain/) ãå©ç¨ã§ãã¾ããé²èªã¯ã¨ãã«ææã§ãã è³¼èªç³ãè¾¼ã¿ã¯ä¸è¨ã®ãã¼ã¸ãã
ããã¯ããè¿äºâ¦3æ³å ããåºã«åºããæç´ã話é¡ã« ã¤ã®ãªã¹ã®å¤§æã¹ã¼ãã¼ãã¼ã±ããã«ããã3æ³å ããã®æç´ãå±ããããã§ãã ã¡ãã£ã¨ã»ã®ã¼ã®ã¨ãããåºå´ã¨ã®ããã¨ããã覧ãã ããã â»å¤§ããªç»åã¯ãã¡ã å·¦å´ã3æ³å ããã®æç´ã ã»ã¤ã³ãºãºãºãºãºãºãºãºãããããããªã¼ã¸ ã©ããã¦ã¿ã¤ã¬ã¼ãã³ã¯ã¿ã¤ã¬ã¼ãã³ã¨å¼ã°ãã¦ããã®ï¼ããªã³ãã³ã£ã¦å¼ã¶ã»ããããã¨æãã¾ãã ãªãªã¼ã»ããã³ã½ã³ããï¼3æ³ï¼1/2ï¼ å³å´ãããã«å¯¾ããã»ã¤ã³ãºããªã¼ã»ã¹ã¼ãã¼ãã¼ã±ããã®ã«ã¹ã¿ãã¼ã»ãµã¼ãã¹ããã®è¿äºã ãªãªã¼ã¸ ãæç´ãã©ãããããã¨ããã¿ã¤ã¬ã¼ãã³ã®ååãããªã³ãã³ã«ããã¢ã¤ãã¢ã¯ã¨ã¦ããã°ãããã¨æãã¾ãããã©ã®ãã¾æ¨¡æ§ããã¯ç¢ºãã«ããªã³ã®ã¾ã ã模æ§ã«è¦ãã¾ãããã¿ã¤ã¬ã¼ãã³ã¨å¼ã°ããçç±ã¯ãããã¼ã¼ããåãã¦ãã®ãã³ãä½ã£ããã³å±ãããããããã©ã«è¦ããã¨æã£ããããªã®ã ã¨æãã¾ããã¡ãã£ã¨ãã
ããã° ãã®ããã°ã¯éå ¬éã«è¨å®ããã¦ãã¾ãã (Access forbidden) ä»ã®ããã°ãæ¢ã ããã°ã©ã³ãã³ã°ï¼å ±éã®ã¸ã£ã³ã«ï¼ 1 è£ã㯠2 æ¾éäºæ â ãå®ã¨ãç»åæã¾ã¨ã 3 AV女åª2chã¾ã¨ã 4 ããã女ç»åéã女åªã»ã¢ãã«ã»ã¢ã¤ãã« 5 ã¨ãç»åã¾ã¨ã ãã£ã¡ãªãå§ããã ãã«ã ã¤ã³ãã©ã¡ã¼ã·ã§ã³ ãªã¯ã¨ã¹ã å©ç¨è¦ç´ é害æ å ± FC2ããã°ã«ã¤ã㦠FCï¼ã®è±å¯ãªæ©è½ ã¹ãããããããã°æ稿 ææãã©ã³ ã¢ã«ãã æ©è½ ããããããã° ãã³ãã¬ã¼ãä¸è¦§ ãã¬ãã ãã¬ããã¨ã¯ï¼ ãã¬ããã©ã³ãã³ã° ãã¬ããã®æ¸ãæ¹ ãã¬ããã¢ãã£ãªã¨ã¤ã ãµãã¼ã ãã«ã ã¤ã³ãã©ã¡ã¼ã·ã§ã³ ãªã¯ã¨ã¹ã å©ç¨è¦ç´ é害æ å ± ã¢ããªã§ãããã°æ稿 FC2ããã ãåãåãã ä¼ç¤¾æ¦è¦ ãã©ã¤ãã·ã¼ããªã·ã¼ èä½æ¨©ã¬ã¤ãã©ã¤ã³ åºåæ²è¼ Copyright(c)1999 FC2, I
ãMOLESKINE Writing Collection éç2æ¬ã»ãã + ã·ã£ã¼ããã¼ãã¯ãã¹ã±ããããã¯ã«çµµãæããããªãéçã§ãã éç2æ¬ããã£ãã1ã¤ãã·ã£ã¼ããã¼(éçåã)ãã·ã¼ã«ãå°ååãã»ããã«ãªã£ã¦ãã¾ãã çã£é»ã§ãå¹³ã¹ã£ããéçã§ãããã®å½¢ãæåã«è¦ãæã使ãã«ããã®ã§ã¯ãªããã¨æãã¾ããããä¸åº¦ãã®å½¢ã«æ £ããã¨ãä»ã®ãã³ããã®å½¢ã«ããããªãã¾ãã éçã®æ¿ãã¯ã2Bã§ããæãããã¦æ¿ãè²ã®è¯ãªã®ã§ããããµã³ã«ãåãã¦ãã¾ãã ã·ã£ã¼ããã¼ã¯ãæ®éã®å½¢ã§ãããã®å½¢ã§å¹³ã¹ã£ããéçã丸ãåãäºãã§ããã®ãããªãã ãä¸æè°ã§ãã ã·ã£ã¼ããã¼ãããè¦ã¦ã¿ãã¨ãMOLESKINEã®æåãããã¾ãã(ä¸ã®åçãæ¯ã®å³ä¸ããã)ã MOLESKINEã®éçãæã£ã¦ããã¨ãçµµãæããããªãã¾ããã©ããã¦ããããªã«çµµãæããããªãã®ãèãã¦ã¿ãã¨ãããéçããæ¨çãããµã³ã®æ¨
天æã»ãã¿ã¼ã»ä¸ç°ä¹ ç¾ãã¾ãçµå§åã¿åããªã女çã®ã»ãã¿ã¼è«æ«é²ã®å·»ã Tweet Share on Tumblr ã«ãã´ãª:ãã¬ã¼ãã¼ã« 2011å¹´05æ17æ¥12:13 æ¥æ¬äººã®ã¤ã³ãµã¤ãã¯ã¼ã¯èãã¯ç°å¸¸ï¼ çã¾ããªããã«èº«ä½ããã«ã¤å¤äººã¯ãã¤ã³ãµã¤ãã¯ã¼ã¯ã«ãèãããã¨ããæè¦ã¯ããã®ã§ãããããçé150ãããã160ãããæããããææããç·©æ¥ãã³ã¼ã¹ã»ãã©ã¼ã ã§ç¸æãå¹»æãããã¨ã«èããã®ãã100ã¡ã¼ãã«ã10ç§å°ã§èµ°ãã人éããç®ã®åããéåãã®åãæ¹ã§ç¸æãããããã¨ã«èããã®ããã²ãã£ã¨ãããã¤ã³ãµã¤ãã¯ã¼ã¯ãç´°ãã工夫ã«èããã®ã¯ãå°æã§ã²å¼±ãªæ¥æ¬äººãã ãããããªã®ããããã¾ããã ä¾ãã°ã½ãããã³ã¯ã®åç°ããã³ãã³ä¸æ¯ã奪ãã¨ãããåç°ã®ãã©ã¼ã ã¯ãã¼ã«ãè¦ã«ããããã®ãªã®ãªã¾ã§å·¦è ãããªã£ã¦ãã¼ã«ã身ä½ã®å½±ã«é ãã¦ãããããã®ããã§140ããããããã®çã150ã
FDAï¼ç±³é£åå»è¬åå±)ã¯15æ¥ãæ¦ç°è¬åå·¥æ¥ï¼å¤§éªå¸ä¸å¤®åºï¼ã®2åç³å°¿ç æ²»çè¬ã¢ã¯ãã¹ï¼ä¸è¬åï¼ããªã°ãªã¿ã¾ã³å¡©é ¸å¡©ï¼ãªã©ããèè±çãªã¹ã¯ãé«ããå¯è½æ§ãããã¨çºè¡¨ãããåæ²»çè¬ã«ã¤ãã¦ã¯ããã©ã³ã¹ã¨ãã¤ãã®å½å±ãåæ§ã®ãªã¹ã¯ãææããæ°è¦ã®å¦æ¹ãè¡ããªãããã«ééããã°ããã ã£ããï¼é¢é£è¨äºï¼ãã©ã³ã¹å½å±ãªã©ããæ¦ç°è¬åã®2åç³å°¿ç æ²»çè¬ãActosããCompetactãã®æ°è¦å¦æ¹ãæ§ããããééï¼ ä»åã®çºè¡¨ã§FDAã¯ãèè±çæ£è ã«ã¯ããªã°ãªã¿ã¾ã³è£½å¤ã使ç¨ããªããã¨ãèè±çæ¢å¾ã®æ£è ã«ä½¿ç¨ããéã¯æ³¨æããªããå¦æ¹ãããã¨ããªã©ãæ¨å¥¨ãã¦ãããããã¯ãFDAãå®æ½ãã¦ããããªã°ãªã¿ã¾ã³å¡©é ¸å¡©ã®èè±çãªã¹ã¯ã«é¢ãã調æ»çµæã®ä¸é解æã«åºã¥ããã®ã解æãã®ãã®ã§ã¯ãæ£è å ¨ä½ã対象ã«ããå ´åãææãªãªã¹ã¯ä¸æã¯èªããããªãã£ããã1年以ä¸ã®æä¸ã§èè±çãªã¹ã¯ãé«ããå¾åãèªã¿åããã¨ãã
ç±³é£åå»è¬åå±ï¼FDAï¼ã¯ã¾ã ãã¤ãªã·ãã©ã¼ã®ã¬ã¤ãã³ã¹ãçå®ãã¦ããªããããã§ã«ãã¤ãªã·ãã©ã¼éçºãç®çã¨ãã14件ã®æ²»é¨è¬ç³è«åç¸è«ãè¡ã£ããã¨ãæããã«ãããããã¯FDAã®StevenãKozlowskiãã¤ãªãã¯ããã¸ã¼è£½åé¨é·ã5æ4æ¥ã®ã»ããã¼ã§è©±ããã åæ°ã¯ä¼æ¥ãç¹å®ããªãã£ããã製åã§ã¯æ¬§å·ã§ãã§ã«æ¿èªããã¦ãããã¤ãªã·ãã©ã¼ãç³è«ãããè¦è¾¼ã¿ã¨ããã ãã¤ãªã·ãã©ã¼ã®ç°¡ç¥æ¿èªæç¶ããè¦å®ãããçç©è£½å¤ä¾¡æ ¼ç«¶äºã»ã¤ããã¼ã·ã§ã³æ³ãï¼The Biologics Price Competition and Innovation Actï¼ã§ã¯ãFDAã«å¯¾ãã¦ç³è«ãåãä»ããåã«ã¬ã¤ãã³ã¹ãçºè¡ãããã¨ãæ±ãã¦ããªããKozlowskié¨é·ã¯ãFDAã¯ç¾å¨ã¬ã¤ãã³ã¹ãæ¤è¨ä¸ã ã¨èª¬æãç³è«è ï¼ä¼æ¥ï¼ããã¬ã¤ãã³ã¹ã«ã¤ãã¦ã®æè¦ãè´ãã¦ããã¨ãããããã¬ã¤ãã³ã¹ããªããã¨ã§ãå½é¢ãç³
ã¢ãã©ãã³ã©ã§éããåªé ãªæé ã¡ãã·ã³æ¹¾æ²¿ãã®å ¥ãæ±ã«é¢ããç±³ãããªãå·ã®å°ããªçºã¢ãã©ãã³ã©ããããã¾ããã海辺ã®ããã«ã«å®¿æ³ãããã¼ã§æ°é®®ãªã·ã¼ãã¼ããå³ãããã»ããå°ãã¼ã«ã®é¸é æãããã綿è±ãæ¼æ¥ã§æ ãããã®çºã«ã¯ãã°ãªã¼ã¯ãªãã¤ãã«ï¼ã®ãªã·ã£å»ºç¯ã¸ã®å帰ï¼æ§å¼ã®åªé ãªä½å® ãæ£è¦ããããæ°ããã®æ²åã«æµ®ãã¶ã»ã³ãã¸ã§ã¼ã¸å³¶ã«ã¯ç½ãç æµãåºããã
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}